Lei Yan
Qingdao University of Science and Technology(CN)Shandong University(CN)Shanxi Medical University(CN)Medical Center Hospital(US)Shanxi Provincial Cancer Hospital(CN)Hubei Provincial Women and Children's Hospital(CN)
Publications by Year
Research Areas
TGF-β signaling in diseases, Hepatitis B Virus Studies, Intracranial Aneurysms: Treatment and Complications, Liver Disease Diagnosis and Treatment, Hepatitis C virus research
Most-Cited Works
- → Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis(2018)1,455 cited
- → Synthesis and Activity of New Aryl- and Heteroaryl-Substituted Pyrazole Inhibitors of the Transforming Growth Factor-β Type I Receptor Kinase Domain(2003)237 cited
- → Preclinical assessment of galunisertib (LY2157299 monohydrate), a first-in-class transforming growth factor-β receptor type I inhibitor(2017)170 cited
- → Synthesis and activity of new aryl- and heteroaryl-substituted 5,6-dihydro-4H-pyrrolo[1,2-b]pyrazole inhibitors of the transforming growth factor-β type I receptor kinase domain(2004)162 cited
- → LY2801653 is an orally bioavailable multi-kinase inhibitor with potent activity against MET, MST1R, and other oncoproteins, and displays anti-tumor activities in mouse xenograft models(2012)161 cited
- →